Bio-studies required for Carvedilol phosphate CR capsules [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2010-01-07 14:38 (6017 d 04:17 ago) – Posting: # 4572
Views: 2,821

Dear Madhava!

❝ [...] what are the BE studies required for Carvedilol phosphate CR capsules

❝ for USFDA submission and also on which strengths it need to conduct studies.

❝ For your information this drug is available as 10, 20, 40, 80 mg capsule

❝ formulations.


FDA's Guidance gives some preliminary information (2 studies: single dose fasting/fed; parent+metabolite). This information applies to the IR tablet. None of the extended release capsules are RLDs. I would suggest contacting FDA's review staff.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
165 visitors (0 registered, 165 guests [including 21 identified bots]).
Forum time: 19:55 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5